事件概述 - 前总统特朗普在白宫新闻发布会上多次建议孕妇不要服用泰诺并敦促母亲不要给婴儿使用该药物 这些言论将泰诺、疫苗与自闭症之间未经证实且部分被推翻的联系公之于众 [1] - 泰诺制造商Kenvue的股价在相关言论导致周一下跌75%后于周二开盘前大幅反弹近5% [2][5] 公司回应与产品风险 - Kenvue本周反驳了其药物与自闭症之间的任何联系并警告称如果孕妇在需要时不使用泰诺可能面临在发烧或使用风险更高的替代品之间做出危险选择 [3] - 公司旗下除泰诺外还生产邦迪、李施德林等家用品牌产品 [3] 市场分析与法律风险 - 花旗投资研究分析师认为特朗普的声明后引发新诉讼的风险有限但负面新闻头条可能对泰诺的消费构成风险 [4] - 公司已应对数百起涉及该产品及其与自闭症 alleged 关联的诉讼但大部分已被驳回 [4] - 分析师预计鉴于缺乏新的科学证据Kenvue股价在周二开盘时将出现积极反应 [4]

WASHINGTON: U.S. President Donald Trump is set to announce on Monday a link between the use of popular over-the-counter pain medication Tylenol and the development of autism during pregnancy, a claim which many doctors dispute. Trump is also slated to suggest leucovorin, a form of folic acid, as a treatment for autism symptoms during a White House event. The Food and Drug Administration published a notice to the Federal Register on Monday approving a version of the drug made by GSK but later withdrew it. Th ...

US President Donald Trump on Monday (September 22) suggested a connection between the use of over-the-counter pain medication Tylenol during pregnancy and the development of autism, a claim that many medical experts dispute.“Taking Tylenol is not good. I'll say it. Not good,” Trump said. "For this reason, they are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary."He added, “You shouldn't give the child a Tylenol every time he gets a shot.”The President also ment ...

The Trump administration on Monday drew an unproven link between autism and pregnant women's use of acetaminophen, the active ingredient in one of the world's most common over-the-counter pain relievers, Kenvue's Tylenol.Officials warned women against using acetaminophen early on in their pregnancy unless they have a fever. That recommendation clashes with a bulk of scientific literature suggesting no causal link between autism and exposure to acetaminophen in the womb. Many over-the-counter drugs contain a ...

公司股价与事件影响 - 强生公司旗下泰诺品牌的母公司Kenvue Inc (KVUE) 股价在周一午盘交易中下跌约6% [2] - 股价下跌的直接原因是市场预期特朗普政府将宣布非处方止痛药泰诺与自闭症风险存在关联 [2] 公司背景与产品信息 - 泰诺品牌由强生公司于2023年分拆出来 成为独立的上市公司Kenvue [3] - Kenvue公司旗下拥有包括邦迪、李施德林和仙特明在内的多个知名家用产品品牌 [3] - 泰诺是美国自1955年就已存在的品牌 其活性成分是对乙酰氨基酚 是一种用于缓解轻微疼痛和退烧的药物 [4] 争议与研究背景 - 联邦卫生官员预计将基于研究提出对孕妇使用对乙酰氨基酚的担忧 包括西奈山和哈佛大学8月的一项综述 该研究提示孕早期使用泰诺可能增加儿童自闭症风险 [5] - 同时有研究指出泰诺通常被认为是安全的 且与自闭症无关 《美国医学会杂志》的一项研究发现孕期使用对乙酰氨基酚与儿童自闭症、多动症或智力残疾风险增加无关 [6] - 泰诺的所有者Kenvue公司发表声明称 活性成分“对乙酰氨基酚不会导致自闭症” [8] 相关药物与市场数据 - 官员们预计将引入一种名为亚叶酸钙的较不知名药物 作为自闭症的潜在治疗方法 [8] - 根据美国疾病控制与预防中心数据 2022年美国每31名8岁儿童中就有1名被诊断患有自闭症 而2000年这一比例为每150名儿童中有1名 [8]

Donald Trump is reportedly expected to claim there is a link between the use of paracetamol in pregnancy and the development of autism - but what does the evidence say?Americans consume more than 40% of all the world's paracetamol, spending in excess of $4bn a year on products containing acetaminophen (as it is known in America - or by its leading brand name, Tylenol). Autism rates in the US are also on the rise - going up from about one in 150 children in the year 2000, to around one in 30 today.There have ...

President Donald Trump is expected to give a Monday afternoon announcement linking the use of popular over-the-counter pain medication Tylenol to the development of autism during pregnancy, a claim wh... ...

公司动态 - 公司临时首席执行官Kirk Perry在仓促安排的会议上试图说服卫生部长 [1] - 公司认为不存在明确联系 [1]

核心事件 - 泰诺生产商Kenvue股价在周五交易中暴跌超过14% [1][3] - 暴跌原因是报道称美国卫生与公众服务部计划发布报告显示泰诺与自闭症存在潜在关联 [1] 产品信息 - 泰诺是非处方药 主要成分为对乙酰氨基酚 用于止痛退烧及缓解感冒流感过敏症状 [2] - 医疗专业领域此前认为含对乙酰氨基酚产品对孕妇安全 [2] 报告内容 - 美国卫生与公众服务部部长Robert F Kennedy Jr计划本月发布关于自闭症潜在成因的报告 [1] - 报告可能显示孕期服用泰诺与低水平维生素叶酸与自闭症存在关联 [1] 市场反应 - 股价暴跌发生在周五下午交易时段 [3] - 事件被标注为持续发展故事 建议关注更新 [4]